You have 9 free searches left this month | for more free features.

Myeloproliferative disorder (P Vera, CMML, ET)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Philadelphia Negative Myeloproliferative Tumors Trial

    Not yet recruiting
    • Philadelphia Negative Myeloproliferative Neoplasms
      • (no location specified)
      Jun 5, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +9 more
      • Los Angeles, California
      • +5 more
      Jan 27, 2023

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

      Not yet recruiting
      • Myeloproliferative Neoplasms (MPNs)
      • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
      • (no location specified)
      Mar 24, 2023

      Acute Myeloid Leukemia, Myeloproliferative Syndrome Trial in France (CPX-351)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myeloproliferative Syndrome
      • Amiens, France
      • +33 more
      Feb 7, 2022

      Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

      Recruiting
      • Primary Myelofibrosis
      • +9 more
      • Observational
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Apr 11, 2022

      Myeloproliferative Tumor Trial in Worldwide (Navitoclax, Ruxolitinib, Celecoxib)

      Recruiting
      • Myeloproliferative Neoplasm
      • Duarte, California
      • +41 more
      Feb 1, 2023

      Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

      Not yet recruiting
      • Myelofibrosis (PMF)
      • +2 more
      • New York, New York
        Ruttenberg Treatment Center
      Apr 18, 2023

      Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial (LP-108, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +2 more
      • (no location specified)
      Nov 29, 2022

      Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

      Active, not recruiting
      • Myelofibrosis
      • Polycythemia Vera
      • Phoenix, Arizona
      • +4 more
      Jun 20, 2022

      Chronic Myeloproliferative Tumors Trial in Germany, Italy, United Kingdom (givinostat)

      Active, not recruiting
      • Chronic Myeloproliferative Neoplasms
      • Berlin, Germany
      • +14 more
      Jun 14, 2021

      Myelofibrosis Trial in Worldwide (PXS-5505)

      Recruiting
      • Myelofibrosis
      • Birmingham, Alabama
      • +19 more
      Nov 28, 2022

      Myelofibrosis, Chronic Myelomonocytic Leukemia Trial in Canada, United States (SL-401)

      Active, not recruiting
      • Myelofibrosis
      • Chronic Myelomonocytic Leukemia
      • Duarte, California
      • +9 more
      Jan 24, 2023

      Assess the Safety of Fedratinib in Korean Myelofibrosis

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Myelofibrosis Trial (Momelotinib)

      Available
      • Myelofibrosis
      • (no location specified)
      Oct 12, 2022

      Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

      Recruiting
      • Polycythemia Vera (PV)
      • P1101 (Ropeginterferon alfa-2b)
      • Toon-shi, Ehime, Japan
      • +5 more
      Jun 13, 2022

      MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

      Recruiting
      • Myelodysplastic Syndromes
      • Myeloproliferative Chronic Myelomonocytic Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Carotid Plaque Burden in Philadelphia Negative

      Recruiting
      • Myeloproliferative Neoplasm
        • Sohag, Egypt
          Faculty of Medicine
        Aug 14, 2023

        Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

        Recruiting
        • Myeloproliferative Disorders
        • +4 more
        • La Jolla, California
        • +184 more
        Aug 22, 2022

        PTSD, MDD, Anxiety Disorders Trial (TF-CBT)

        Completed
        • Posttraumatic Stress Disorder
        • +2 more
        • TF-CBT
        • (no location specified)
        Aug 23, 2022

        Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

        Recruiting
        • Primary Myelofibrosis
        • +2 more
        • Birmingham, Alabama
        • +151 more
        Aug 22, 2022